A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE

被引：0
|
作者：
Leinwand, B. [1 ]
机构：
[1] Avalere Hlth LLC, Washington, DC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1426
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI7
引用
收藏
页码：A632 / A633
页数：2
相关论文
共 50 条
  • [1] Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
    Jiang, Yiling
    Sarpong, Eric M.
    Sears, Pamela
    Obi, Engels N.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 111 - 126
  • [2] Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
    Yiling Jiang
    Eric M. Sarpong
    Pamela Sears
    Engels N. Obi
    [J]. Infectious Diseases and Therapy, 2022, 11 : 111 - 126
  • [3] Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection
    Whitney, Laura
    Nesnas, John
    Planche, Timothy
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [4] Fidaxomicin versus Vancomycin for Clostridium difficile Infection
    Louie, Thomas J.
    Miller, Mark A.
    Mullane, Kathleen M.
    Weiss, Karl
    Lentnek, Arnold
    Golan, Yoav
    Gorbach, Sherwood
    Sears, Pamela
    Shue, Youe-Kong
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 422 - 431
  • [5] Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
    Maass, Sandra
    Otto, Andreas
    Albrecht, Dirk
    Riedel, Katharina
    Trautwein-Schult, Anke
    Becher, Doerte
    [J]. CELLS, 2018, 7 (11)
  • [6] Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
    Comely, Oliver A.
    Miller, Mark A.
    Louie, Thomas J.
    Crook, Derrick W.
    Gorbach, Sherwood L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 : S154 - S161
  • [7] COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION: A NETWORK META-ANALYSIS
    Okumura, H.
    Fukushima, A.
    Taieb, V
    Shoji, S.
    English, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S222 - S222
  • [8] Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
    Lee, Christine
    Louie, Thomas J.
    Weiss, Karl
    Valiquette, Louis
    Gerson, Marvin
    Arnott, Wendy
    Gorbach, Sherwood L.
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016 : 1 - 8
  • [9] Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis
    Okumura, Hiroyuki
    Fukushima, Ayako
    Taieb, Vanessa
    Shoji, Shingo
    English, Marci
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (01) : 43 - 50
  • [10] COST-EFFECTIVENESS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN SPAIN
    Watt, M.
    de Nigris, E.
    McCrea, C.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A784 - A784
12345